Literature DB >> 23219668

Postdischarge surveillance following delivery: the incidence of infections and associated factors.

Aida Bianco1, Simona Roccia, Carmelo G A Nobile, Claudia Pileggi, Maria Pavia.   

Abstract

BACKGROUND: To assess the effectiveness of a postdischarge surveillance system to reveal cases of postpartum infections that could be missed by the current in-hospital routine surveillance and to identify predictors of postpartum infections.
METHODS: The prospective surveillance included obstetrics patients. The information recorded included sociodemographic characteristics, infection-predisposing conditions, documentation of extrinsic risk factors, variables related to pregnancy and delivery, and variables related to each patient's newborn. A telephone interview on Day 30 after hospital discharge was performed to retrieve information related to signs and symptoms of infection.
RESULTS: One thousand seven hundred five patients agreed to participate for a response rate of 93%. One hundred forty-nine (8.9%) patients contacted by telephone reported at least 1 episode of infection within 30 days of discharge. There were 24 infections occurring during hospitalization, representing only 16.1% of all infections. There was an increased risk of postpartum infections in women with complications during labor, in those who had a caesarean delivery, and in those who reported alcohol consumption during pregnancy.
CONCLUSION: Our study demonstrated the need for implementing postdischarge surveillance programs for obstetrics patients that also identify infections following vaginal delivery. Postdischarge surveillance by telephone contact proved to be a feasible and effective method.
Copyright © 2013 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23219668     DOI: 10.1016/j.ajic.2012.06.011

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  6 in total

1.  Post partum infections: A review for the non-OBGYN.

Authors:  E Dalton; E Castillo
Journal:  Obstet Med       Date:  2014-02-27

2.  Diagnosing Post-Cesarean Surgical Site Infections in Rural Rwanda: Development, Validation, and Field Testing of a Screening Algorithm for Use by Community Health Workers.

Authors:  Teena Cherian; Bethany Hedt-Gauthier; Theoneste Nkurunziza; Kristin Sonderman; Magdalena Anna Gruendl; Edison Nihiwacu; Bahati Ramadhan; Erick Gaju; Evrard Nahimana; Caste Habiyakare; Georges Ntakiyiruta; Alexi Matousek; Robert Riviello; Fredrick Kateera
Journal:  Surg Infect (Larchmt)       Date:  2020-05-18       Impact factor: 2.150

3.  Short-Term Postoperative Outcomes between 4% Icodextrin Solution and Hyaluronic Acid- Carboxymethyl Cellulose Membrane during Emergency Cesarean Section.

Authors:  Kuan-Sheng Lee; Jian-Pei Huang
Journal:  J Clin Med       Date:  2019-08-18       Impact factor: 4.241

4.  mHealth-community health worker telemedicine intervention for surgical site infection diagnosis: a prospective study among women delivering via caesarean section in rural Rwanda.

Authors:  Theoneste Nkurunziza; Wendy Williams; Fredrick Kateera; Robert Riviello; Anne Niyigena; Elizabeth Miranda; Laban Bikorimana; Jonathan Nkurunziza; Lotta Velin; Andrea S Goodman; Alex Matousek; Stefanie J Klug; Erick Gaju; Bethany L Hedt-Gauthier
Journal:  BMJ Glob Health       Date:  2022-07

5.  Postnatal infection surveillance by telephone in Dar es Salaam, Tanzania: An observational cohort study.

Authors:  Susannah L Woodd; Abdunoor M Kabanywanyi; Andrea M Rehman; Oona M R Campbell; Asila Kagambo; Warda Martiasi; Louise M TinaDay; Alexander M Aiken; Wendy J Graham
Journal:  PLoS One       Date:  2021-07-01       Impact factor: 3.240

6.  Incidence of maternal peripartum infection: A systematic review and meta-analysis.

Authors:  Susannah L Woodd; Ana Montoya; Maria Barreix; Li Pi; Clara Calvert; Andrea M Rehman; Doris Chou; Oona M R Campbell
Journal:  PLoS Med       Date:  2019-12-10       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.